Antibody-drug conjugates (ADC), a fast-growing next-generation cancer treatment, have become an investment hotspot due to its potential to become mainstream…
Read More »Cancer
Shares of Chinese drug firm Akeso – likened by some Western media outlets to artificial intelligence start-up DeepSeek – rose…
Read More »China’s healthcare sector is on track to secure record fundraising this year, driven by robust global investor demand and growth…
Read More »Jiangsu Hengrui Pharmaceuticals and Hansoh Pharmaceutical Group, two of China’s largest drug makers, are expected to report significantly improved profits,…
Read More »Clem Burke, the iconic drummer of Blondie, has passed away at the age of 70 following a private battle with…
Read More »China has added dozens of new drugs to its health insurance reimbursement list, signalling support for innovative treatments while keeping…
Read More »HutchMed aims to establish a bigger presence in the city when the first wet laboratories at the much larger Hong…
Read More »Evive Biotech, a unit of Shenzhen-listed Yifan Pharmaceutical, aims to break the dominance of American drugs developer Amgen in the…
Read More »Hutchison China MediTech (Chi-Med), whose stock has surged 70 per cent in London over the past six months, expects to…
Read More »Three hospital systems across England have begun a live clinical trial of AI technology designed to detect and grade prostate…
Read More »








